Trials / Completed
CompletedNCT00518089
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 859 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gatifloxacin 0.5% eye drops | Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily |
| DRUG | placebo eye drops | Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2007-08-20
- Last updated
- 2019-04-23
- Results posted
- 2011-11-30
Locations
2 sites across 2 countries: United States, India
Source: ClinicalTrials.gov record NCT00518089. Inclusion in this directory is not an endorsement.